Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Jacobs

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
Journal of Medical Genetics|April 7, 2018
Current detection rates and time-to-detection of all identifiable <i>BRCA</i> carriers in the Greater London populationRanjit Manchanda, Oleg Blyuss, Faiza Gaba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General PopulationOleg Blyuss, Matthew Burnell, Andy Ryan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
Clinical Chemistry|January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancerJohn F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
International Journal of Cancer|October 15, 2013
Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screeningJohannes W Pedersen, Aleksandra Gentry-Maharaj, Alexander Nøstdal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Development of a multimarker assay for early detection of ovarian cancerZoya Yurkovetsky, Steven Skates, Aleksey Lomakin, et al.
Resuscitation|October 20, 2010
Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment RecommendationsJasmeet Soar, Mary E Mancini, Farhan Bhanji, et al.
Circulation|October 20, 2010
Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment RecommendationsMary E Mancini, Jasmeet Soar, Farhan Bhanji, et al.
Resuscitation|October 20, 2010
Part 5: Adult basic life support: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendationsRudolph W Koster, Michael R Sayre, Martin Botha, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
Journal of Medical Genetics|April 7, 2018
Current detection rates and time-to-detection of all identifiable <i>BRCA</i> carriers in the Greater London populationRanjit Manchanda, Oleg Blyuss, Faiza Gaba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General PopulationOleg Blyuss, Matthew Burnell, Andy Ryan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
Clinical Chemistry|January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancerJohn F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
International Journal of Cancer|October 15, 2013
Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screeningJohannes W Pedersen, Aleksandra Gentry-Maharaj, Alexander Nøstdal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Development of a multimarker assay for early detection of ovarian cancerZoya Yurkovetsky, Steven Skates, Aleksey Lomakin, et al.
Resuscitation|October 20, 2010
Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment RecommendationsJasmeet Soar, Mary E Mancini, Farhan Bhanji, et al.
Circulation|October 20, 2010
Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment RecommendationsMary E Mancini, Jasmeet Soar, Farhan Bhanji, et al.
Resuscitation|October 20, 2010
Part 5: Adult basic life support: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendationsRudolph W Koster, Michael R Sayre, Martin Botha, et al.
Pageof 19